Mateja Kova Ci C

Title: Innovations of Mateja Kova Ci C in Pharmaceutical Chemistry

Introduction

Mateja Kova Ci C is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel inclusion complexes for medicinal applications. His work focuses on enhancing the efficacy of clavulanic acid, a crucial component in the treatment of infectious diseases.

Latest Patents

Mateja Kova Ci C holds 1 patent for his innovative process involving inclusion complexes of clavulanic acid and its alkali salts. The patent describes a new method for preparing alkali clavulanate from an aqueous solution of crude clavulanic acid. This process utilizes a hydrophobic β-cyclodextrin derivative, which is extracted in an equimolar ratio with clavulanic acid. The resulting inclusion complexes are isolated, purified, and converted into alkali clavulanate, which is essential for creating effective pharmaceutical formulations.

Career Highlights

Mateja Kova Ci C is associated with Lek, Tovarna Farmacevtskih in Kemicnih, a prominent pharmaceutical company in Slovenia. His work at Lek has allowed him to focus on innovative solutions that improve drug formulations and therapeutic outcomes. His research has contributed to the development of valuable medicaments used in the therapy of infectious diseases.

Collaborations

Mateja has collaborated with esteemed colleagues, including Janko Zmitek and Darja Ferčeji-Temeljotov, who have supported his research endeavors. Their combined expertise has furthered the understanding and application of inclusion complexes in pharmaceutical science.

Conclusion

Mateja Kova Ci C's innovative work in the field of pharmaceutical chemistry exemplifies the importance of research and development in creating effective treatments for infectious diseases. His contributions continue to impact the industry positively.